
This episode discusses advancements in gastric and GEJ cancer treatment through targeted and immunotherapeutic approaches.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WZY865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027. Scaling New Heights in Gastric/GEJ Cancer: Aligning the Evidence on Targeted and Immunotherapeutic Approaches Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hope For Stomach Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent medical education grants from AstraZeneca, BeOne Medicines, and Jazz Pharmaceuticals. Disclosure information is available at…
Guest: Yelena Y. Janjigian, MD
AstraZeneca, BeOne Medicines, Jazz Pharmaceuticals
Organizations: PVI, PeerView Institute for Medical Education, Hope For Stomach Cancer, Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC)
Explore listener stats, chart rankings, contacts and more on the PeerView Clinical Pharmacology CME/CNE/CPE Video podcast page.